Showing 5651-5660 of 5956 results for "".
- Spectralis High Magnification Module Receives CE Markinghttps://modernod.com/news/spectralis-high-magnification-module-receives-ce-marking/2476331/Heidelberg Engineering announced CE Mark approval of the Spectralis High Magnification Module. With the addition of a lens and software upgrade, the new module enables visualization of the ocular
- Johnson & Johnson Vision Announces Availability in Europe of Tecnis Eyhance IOLhttps://modernod.com/news/johnson-johnson-vision-announces-availability-in-europe-of-tecnis-eyhance-iol/2476332/Johnson & Johnson Vision announced the launch of its Tecnis Eyhance IOL in Europe. This next-generation monofocal IOL allows patients to experience high-quality vision at both intermediate and far distances. “With the availability of Tecnis Eyhance IOL in Europe, we are proud to deliv
- Clinical Trials Planned for Iris-Recognition-Based Patient Identification Softwarehttps://modernod.com/news/clinical-trials-planned-for-iris-recognition-based-patient-identification-software/2476333/Patientory and UK-based IrisGuard announced a collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures. The HIPAA-compliant Patientory App, which already adheres to strict security requirements, will utilize the be
- Zeimer Manufactured its 1,000th Laser at its Berne Production Facilityhttps://modernod.com/news/zeimer-manufactured-its-1000th-laser-at-its-berne-production-facility/2476335/More than 20 years ago, Ziemer Ophthalmic Systems AG, based in the Berne Seeland region of Switzerland began providing eye surgeons with high-quality products. The company started with a diamond knife and soon develop
- MacuLogix Hosts Inaugural AMD Speaker Alliancehttps://modernod.com/news/maculogix-hosts-inaugural-amd-speaker-alliance/2476336/MacuLogix hosted the industry’s first AMD Speaker Alliance meeting. The peer-to-peer event was attended by 25 optometric key opinion leaders who are at the front lines of minimizing vision loss due to AMD and other retinal disease. “This meeting is helping us kick off a movement in our pro
- University of Alberta Scientists Pinpoint a Cause of Pigmentary Glaucomahttps://modernod.com/news/university-of-alberta-scientists-pinpoint-a-cause-of-pigmentary-glaucoma/2476337/An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition. “People who traditionally we wouldn’t think of having glaucoma—young males in their 20s and 30s—are at particular risk
- Investigators Seek Optimized Ophthalmology Clinical Trial Outcomeshttps://modernod.com/news/investigators-seek-optimized-ophthalmology-clinical-trial-outcomes/2476338/Investigators from Brown University and Johns Hopkins University shared new considerations from 3 groups working to standardize Core Outcome Sets (COSs), to increase the utility of results from randomized clinical trials for 3 eye conditions: age-related macular degeneration (AMD), refractive err
- Ranibizumab and Aflibercept Prompt Comparable Visual Gain in AMDhttps://modernod.com/news/ranibizumab-and-aflibercept-prompt-comparable-visual-gain-in-amd/2476339/In patients with neovascular age-related macular degeneration (AMD), aflibercept and ranibizumab achieve similar average visual acuity increases, according Australian researchers, as reported by Reuters. In a January 24 online paper in JAMA Ophthalmology, Dr. Mark C. Gillies of Sy
- Lutronic Vision Initiates Preclinical Trial of R:GEN Laser for the Treatment of Dry AMDhttps://modernod.com/news/lutronic-vision-initiates-preclinical-trial-of-rgen-laser-for-the-treatment-of-dry-amd/2476343/Lutronic Vision announced that it has initiated a preclinical trial to determine the optimal setting for its R:GEN laser for the treatment of the dry form of age-related macular degeneration (AMD). This study has been initiated at the University of Southern California with Stan Louie, PharmD, Pr
- Controlled Trial Shows Promise of Donated Stem Cells in Restoring Visionhttps://modernod.com/news/controlled-trial-shows-promise-of-donated-stem-cells-in-restoring-vision/2476345/A study in STEM CELLS Translational Medicine provides a deeper and clearer understanding of how patients suffering vision loss in both eyes due to limbal stem cell deficiency (LSCD) might benefit from a stem cell transplant using donated cells. This is the first ra